CDAS:  Caliper's In Vitro & In Vivo Contract Research Organization

Caliper Discovery Alliances & Services (CDAS) was formed through the acquisition of two recognized leaders in the performance of contract research, NovaScreen Biosciences, a provider of in vitro drug discovery services and Xenogen Biosciences, a provider of in vivo target and compound evaluation programs.  CDAS has assembled a wide range of drug discovery and development outsourcing solutions that enable pharmaceutical and biotechnology companies to reduce costs while accelerating the pace and clinical relevance of drug discovery research.

If you have any problem locating the tools or services you need, or if you have any questions about our 
CDAS - in vitro or in vivo programs, please contact us.